HEALTHALLAFRICA
Rwanda: €15m Vaccine Clinical Trial On Mosquito-Borne Viral Disease Launched
A €15 million multicountry clinical trial for a vaccine against chikungunya, a mosquito-borne viral disease often mistaken for malaria, has been launched in Rwanda's Kigali. The initiative aims to accelerate vaccine development.
Related Signal
Adjacent reporting
- Moderna gets $50 million to develop mRNA Ebola vaccine against Bundibugyo
- STAT+: Global coalition to fast-track three vaccines targeting Ebola outbreak with $62 million in funding
- Moderna gets $50M investment for Ebola vaccine candidate
- Sudan: Sudan Approves $139 Million Proposal to Combat Malaria, Tuberculosis, and HIV/Aids
- Google wants to release up to 32 million ‘good’ mosquitoes in California and Florida
- Exclusive: Race begins to trial Ebola drugs amid current outbreak